Expanded Disability Status Scale (EDSS)
Showing 1 - 25 of >10,000
Multiple Sclerosis Trial (360-degree Turn Test, Expanded Disability Status Scale, Perceived Exertion)
Not yet recruiting
- Multiple Sclerosis
- 360-degree Turn Test
- +2 more
- (no location specified)
Apr 9, 2023
Multiple Sclerosis Trial in Denizli (Expanded Disability Status Scale, pulmonary function test, International Physical Activity
Completed
- Multiple Sclerosis
- Expanded Disability Status Scale, pulmonary function test, International Physical Activity Questionnaire - Short Form, 6 minute walk test
-
Denizli, TurkeyPamukkale University
Jan 24, 2023
CogMS - A Real-world Study Into Cognitive Impairment in People
Recruiting
- Multiple Sclerosis
- Custom study version of icompanion app
-
Fort Collins, Colorado
- +8 more
Jan 31, 2023
Multiple Sclerosis (MS) Trial in Basel, Luzern 16, Rheinfelden (Neurostatus-SMARTCARE, Standard Neurostatus-EDSS)
Recruiting
- Multiple Sclerosis (MS)
- Neurostatus-SMARTCARE
- Standard Neurostatus-EDSS
-
Basel, Switzerland
- +2 more
Jan 2, 2023
Comprehensive Evaluation in Patients With Meniere's Disease
Not yet recruiting
- Meniere Disease
- +3 more
- Case report form
- +22 more
- (no location specified)
Apr 25, 2023
Fatigue, Functionality, Multiple Sclerosis Trial in Denizli (Nine-Hole Peg Test (NHPT))
Completed
- Fatigue
- +3 more
- Nine-Hole Peg Test (NHPT)
-
Denizli, TurkeyPamukkale Unıversity
May 25, 2023
Neuromyelitis Optica Spectrum Disorders, Pain Trial in Guangzhou (electroacupuncture)
Completed
- Neuromyelitis Optica Spectrum Disorders
- Pain
- electroacupuncture
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Chinese Medicine
May 20, 2023
Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica
- Efgartigimod
- Intravenous methylprednisolone (IVMP) and Efgartigimod
- IVMP
- (no location specified)
Nov 1, 2023
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States
Active, not recruiting
- Primary Progressive Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- ATA188
- Placebo
-
La Jolla, California
- +33 more
Jul 21, 2022
Multiple Sclerosis Trial in La Laguna (Dry needling)
Completed
- Multiple Sclerosis
- Dry needling
-
La Laguna, Santa Cruz De Tenerife, SpainHospital Universitario de Canarias
Apr 27, 2022
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Inebilizumab
- oral immunosuppressant
- (no location specified)
Jun 5, 2023
Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorders
- (no location specified)
Sep 29, 2023
Relapsing-Remitting Multiple Sclerosis Trial in Hamburg, Mannheim (Autologous Hematopoietic Stem Cell Transplantation,
Terminated
- Relapsing-Remitting Multiple Sclerosis
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Hamburg, Germany
- +1 more
Mar 1, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in Switzerland (serum Neurofilament Filament Light chain (sNfL) monitoring)
Not yet recruiting
- Multiple Sclerosis, Relapsing-Remitting
- serum Neurofilament Filament Light chain (sNfL) monitoring
-
Basel, Basel Stadt, Switzerland
- +7 more
Oct 17, 2023
Multiple Sclerosis Trial in Amman (Telko plus conventional physical therapy (CPT))
Recruiting
- Multiple Sclerosis
- Telko plus conventional physical therapy (CPT)
-
Amman, JordanIsra University
Aug 2, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Isfahan (Azathioprine, Rituximab)
Completed
- Neuromyelitis Optica Spectrum Disorder
-
Isfahan, Iran, Islamic Republic ofKashani Hospital
Sep 29, 2020
Multiple Sclerosis Trial in Montreal (Eye-Tracking)
Not yet recruiting
- Multiple Sclerosis
- Eye-Tracking
-
Montreal, Quebec, CanadaGenge Partners, Inc.
Dec 13, 2022
![](/image/sponsor/irccs_centro_neurolesi_"bonino-pulejo")
Purpose of This Study is to Verify the Use of Vibrations on Fatigue in Patients With MS Trial in Messina (vibra)
Recruiting
- Purpose of This Study is to Verify the Use of Vibrations on Fatigue in Patients With MS
- vibra
-
Messina, Sicily, ItalyIrccs Neurolesi Centro Bonino Pulejo
Mar 14, 2023
Multiple Sclerosis Trial in New York (Intrathecal MSC-NP injection, Intrathecal saline injection)
Active, not recruiting
- Multiple Sclerosis
- Intrathecal MSC-NP injection
- Intrathecal saline injection
-
New York, New YorkTisch MS Research Center of New York
Oct 25, 2022
Czech Pharmaco-epidemiological Study on Disease Modifying Drugs
Completed
- Multiple Sclerosis
- interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
-
Prague, CzechiaIMPULS Endowment Fund
Mar 7, 2023
Delirium, Pain, Back, Spinal Fusion Trial in Iowa City (drug, diagnostic test, other)
Not yet recruiting
- Delirium
- +3 more
- Thoracolumbar Interfascial Plane (TLIP) Block of bupivacaine
- +16 more
-
Iowa City, IowaUniversity of Iowa
Jul 12, 2022
NMO Spectrum Disorder Trial in Tianjin (Baricitinib)
Not yet recruiting
- NMO Spectrum Disorder
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Mar 18, 2023
Multiple Sclerosis, Progressive Multiple Sclerosis Trial in Bergen (Nicotinamid riboside, Placebo)
Not yet recruiting
- Multiple Sclerosis
- Progressive Multiple Sclerosis
- Nicotinamid riboside
- Placebo
-
Bergen, NorwayHaukeland University Hospital
Feb 22, 2023
MS Patients Treated With Sphingosine-1-phosphate Receptor
Recruiting
- Multiple Sclerosis
- S1PR analysis on immune cells
-
Bern, SwitzerlandNeurology department
Apr 12, 2023
Neuromyelitis Optica Trial in Hangzhou (CD19 CAR-T cells injection)
Recruiting
- Neuromyelitis Optica
- CD19 CAR-T cells injection
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Apr 12, 2023